KUNGSBACKA, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR) is launching the G5 Series™, a ground-breaking series of solutions for in-vitro fertilization. The first presentation is to be made at the European reproduction congress, ESHRE, that this year is being held in Lyon in France from July 1-4. Several years’ research and development work into embryos’ need for nutrition and protection during assisted reproduction now culminates in the introduction of the G5 Series™.
